Immunologic Research

Papers
(The H4-Index of Immunologic Research is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
The effect of mutatio-type on proteo-phenotype and clinico-phenotype in selected primary immunodeficiencies64
B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia62
Somatic hypermutation defects in two adult hyper immunoglobulin M patients61
MiR-29a-3p negatively regulates circulating Tfh memory cells in patients with Graves’ disease by targeting ICOS59
Quantitative evaluation of citrullinated fibrinogen for detection of neutrophil extracellular traps55
Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis44
Belimumab 10 years later: how drug positioning has changed40
A case of atypical infantile de novo antiphospholipid syndrome presenting with neonatal ischemic stroke without any triggering risk factors as a “second hit” and review of the literature38
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis35
Rapid generation of an RBL cellular model to study proteins that cause allergenic reactions in vitro35
Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey34
Hypoxia modulates human mast cell adhesion to hyaluronic acid27
The cGAS-STING axis: a comprehensive review from immune defense to disease pathogenesis26
Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance25
PS77: a novel peptide with α-helical structure for targeted anti-inflammatory therapy in biomaterials design25
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer25
Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages23
A ubiquitin–proteasome system-related signature to predict prognosis, immune infiltration, and therapy efficacy for breast cancer22
ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis21
Clinical relevance and frequency of cytoplasmic patterns observed in ANA-Hep-2: experience of Cairo University Hospitals19
0.05272912979126